Preventative strategies for periampullary tumours in FAP

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Wallace, M H ^a   Phillips, R K S ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Duodenal polyposis; Familial adenomatous polyposis (FAP); Periampullary cancer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ADENOMATOUS POLYP; CANCER RISK; CANCER SCREENING; CANCER STAGING; CAUSE OF DEATH; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; DUODENUM TUMOR; FAMILIAL POLYPOSIS; HUMAN; PRIORITY JOURNAL; VATER PAPILLA TUMOR;

EID: 0032776696     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S201     Document Type: Conference Paper

References (19)

1. Nugent, K.P., A.D. Spigelman, and R.K. Phillips, Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. D Colon Rectum, 1993. 36(11): p. 1059-62.
2. Belchetz, L.A., et al., Changing causes of mortality in patients with familial adenomatous polyposis. D Colon Rectum, 1996. 39: p. 384-7.
3. Arvanitis, M.L. et al., Mortality in patients with familial adenomatous polyposis. D Colon Rectum, 1990. 33(8): p. 639-42.
4. Spigelman, A.D. et al., Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet, 1989. 2(8666): p. 783-5.
5. Spigelman, A.D. et al., Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol, 1994. 47(8): p. 709-10.
6. Kashiwagi, H. et al., Over expression of p53 in duodenal tumours in patients with familial adenomatous polyposis. Br J Surg, 1996. 83: p. 225-8.
7. Offerhaus, G.J. et al., The risk of upper gastrointestinal cancer in familial adenomatous polyposis [see comments]. Gastroenterology, 1992. 102(6): p. 1980-2.
8. Kashiwagi, H. et al., Surveillance of ampullary adenomas in familial adenomatous polyposis [letter]. Lancet. 1994. 344(8936): p. 1582.
9. Vasen, H.F.A. et al., Decision-analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut, 1997. 40(6): p. 716-9.
10. Davies, D.R. et al., Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J of Hum Genet. 1995. 57(5): p. 1151-8.
11. Evans, D.G.R., S.P. Guy, and N. Thakker, Non penetrance and late appearance of polyps in families with familial adenomatous polyposis. Gut, 1993. 34: p. 1389-1893.
12. Sanabria, J.R. et al., Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. Am J Surg, 1996. 171(1): p. 136-40.
13. Milkvy, P. et al., Photodynamic therapy for polyposis in familial adenomatous polyposis. Euro J Cancer, 1995. 31A(7/8): p. 1160-65.
14. Nugent, K.P. et al., Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg, 1993. 80(12): p. 1618-9.
15. Seow-Choen, F., V. Vijayan, and V. Keng. Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis. Br J of Surg, 1996. 83: p. 1763-6.
16. Penna, C. et al., Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: an experience of two European centres. Br J Surg, 1993. 80: p. 1027-9.
17. Penna, C. et al., Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis. Br J Surg, 1998. 85: p. 665-8.
18. Scales, D.K. et al., High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis. Gut, 1995. 36(6): p. 918-21.
19. Hargest, R. and R. Williamson, Expression of the APC gene after transfection into a colonic cancer cell line. Gut, 1995. 37(6): p. 826-9.